PRA launches ‘all in one’ national market measurement tool

By Melissa Fassbender contact

- Last updated on GMT

(Image: Getty/agsandrew)
(Image: Getty/agsandrew)

Related tags: Pra health sciences, Symphony Health

PRA Health Sciences’ wholly-owned subsidiary, Symphony Health, has launched a ‘first of its kind’ national market measurement solution integrating prescriber, patient, and payer insights.

The new tool – Metys – is the “first fully integrated, single access, all in one national market measurement solution” ​available from a contract research organization (CRO), said Barbara Aldieri, senior director, product management at Symphony Health, a PRA Health Sciences wholly-owned subsidiary.

“We are focused on delivering solutions that will move our client’s businesses forward – which means integrating prescriber, patient and payer insights and analytics together in one place. That’s really how impactful, business driving insights are developed,”​ she told us.

Metys is powered by Symphony’s ‘Integrated Dataverse’ (IDV) and provides customer’s ‘numerous’ benefits, said Aldieri.

“All-in centralized access to prescription, non-retail, integrated sales, source of business and patient national metrics significantly improves clients’ ease and time to insights,”​ she added.

The tool also provides the diagnosis in prescription transactions and regular updates to support ‘near real-time’ decision making. It also features predefined graphics to visualize performance trends, a report builder, and single-click exports.

PRA Health Sciences acquired Symphony Health for $530m in 2017​. The company provides data, analytics, and technology solutions for biopharmaceutical manufacturers, health care providers, and payers.

Related topics: Clinical Development

Related news

Show more

Follow us

Products

View more

Webinars